Biosynex S.A.
ALBIO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 8.8% | -52.7% | -48.6% | – |
| Gross Profit | -€0 | €0 | €0 | €0 |
| % Margin | -19.8% | 52.8% | 32.8% | 47.7% |
| EBITDA | -€0 | -€0 | €0 | €0 |
| % Margin | -17.6% | -11% | 23.8% | 38.3% |
| Net Income | -€0 | -€0 | €0 | €0 |
| % Margin | -42.8% | -39.7% | 8% | 27.2% |
| EPS Diluted | -3.32 | -2.85 | 1.26 | 8.27 |
| % Growth | -16.5% | -326.2% | -84.8% | – |
| Operating Cash Flow | -€0 | -€0 | €0 | €0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€0 | -€0 | -€0 | €0 |